• ONX-0914 (PR-957): Immunoproteasome Inhibition in Autoimmune

  2026-06-11

  Explore ONX-0914 (PR-957) as a highly selective immunoproteasome inhibitor, with new scientific insights on its role in cytokine modulation and autoimmune disease research. This article uniquely analyzes the latest mechanistic discoveries and their impact on experimental strategy.

• Bispecific Antibodies Against MPXV: Characterization and Pro

  2026-06-11

  This study systematically characterizes monoclonal antibodies targeting the major mpox virus antigens M1R and B6R, leading to the design of bispecific antibodies with superior antiviral efficacy. The work advances the understanding of orthopoxvirus immunity and provides a framework for the development of broad-spectrum antibody therapeutics.

• Polymeric Nanoplatform Boosts cGAS-STING for TAM Reprogrammi

  2026-06-10

  The referenced study introduces a mannose-modified, pH-responsive nanoplatform co-delivering R848 and 2'3'-cGAMP to target tumor-associated macrophages (TAMs). This approach enhances STING-mediated innate immune response, promotes macrophage polarization, and synergizes with immune checkpoint blockade to improve antitumor immunity and survival in preclinical models.

• Reliable Cytokine Assays with Recombinant Human Oncostatin M

  2026-06-10

  This article addresses key challenges in cell viability and proliferation assays by applying Recombinant Human Oncostatin M (E.coli, Tag Free, Lyophilized) (SKU P1045) for robust, reproducible data. Backed by quantitative metrics and peer-reviewed studies, the article guides researchers in optimizing cytokine modulation protocols and selecting high-purity, E.coli-expressed, tag-free OSM for sensitive and consistent results.

• Lyotropic Phase Behavior of Coil-Bottlebrush Diblocks in Ion

  2026-06-09

  This study demonstrates that coil-bottlebrush diblock copolymers self-assemble into diverse network nanostructures in alkylimidazolium-based ionic liquids, and that these morphologies are surprisingly insensitive to changes in the ionic liquid’s alkyl chain length. These findings relax longstanding compositional and solvent constraints, enabling broader and more flexible design of nanostructured polymer materials.

• BAPTA-AM in Translational Research: From Calcium Control to

  2026-06-09

  This thought-leadership article explores how BAPTA-AM redefines the landscape of translational research by enabling precision intracellular calcium modulation. Integrating mechanistic nuance—such as its dual role in chelating calcium and blocking potassium channels—with insights from recent findings on PANoptosis in cardiac injury, the article offers actionable protocol guidance and strategic perspective for researchers. It contextualizes APExBIO’s BAPTA-AM amid evolving challenges in cardiovascular and neurobiological assay design, advocating for rigorous, reproducible workflows that bridge basic discovery and preclinical impact.

• Phosphatase Inhibitor Cocktail 1: Precision in Phosphorylati

  2026-06-08

  Phosphatase Inhibitor Cocktail 1 (100X in DMSO) offers robust, validated inhibition of alkaline and serine/threonine phosphatases, enabling accurate protein phosphorylation preservation during sample preparation. This cocktail is essential for reproducible phosphoproteomic analysis and Western blot workflows, as supported by peer-reviewed and product data.

• Entecavir (BA1816): Benchmark Inhibitor for Chronic HBV Rese

  2026-06-08

  Entecavir (BMS200475) is a potent, selective hepatitis B virus DNA polymerase inhibitor with proven efficacy against both wild-type and lamivudine-resistant HBV. Its nanomolar in vitro potency and low clinical resistance rate establish it as a benchmark for chronic hepatitis B virus replication inhibition. APExBIO provides validated, research-grade Entecavir (SKU BA1816) for laboratory and translational workflows.

• PARP7 Inhibition Stabilizes STAT1/STAT2 and Relieves EAE in

  2026-06-07

  Xu et al. reveal that PARP7 suppresses type I interferon signaling by promoting the autophagic degradation of STAT1 and STAT2 via ADP-ribosylation. Inhibiting PARP7 restores STAT1/STAT2 levels, enhancing interferon responses and alleviating experimental autoimmune encephalomyelitis (EAE) symptoms in mice, pointing to new therapeutic avenues for multiple sclerosis research.

• Epacadostat (INCB024360) in Immuno-Oncology: Protocols & Opt

  2026-06-06

  Epacadostat (INCB024360) unlocks precision immuno-oncology workflows by targeting IDO1-driven immune suppression. This article bridges innovative whole-blood stimulation protocols with actionable troubleshooting and advanced use-cases to help researchers maximize immune modulation and assay performance.

• Vitamin D/VDR Signaling Drives Endometrial Decidualization

  2026-06-05

  A recent study delineates how 1,25-dihydroxy vitamin D3 (Calcitriol) enhances decidualization of human endometrial stromal cells via vitamin D receptor (VDR)-mediated mechanisms. These findings clarify the molecular crosstalk between vitamin D signaling and estrogen pathways, informing future research on endometrial receptivity and infertility.

• TRPV1+ Nerve Stimulation Suppresses Systemic Inflammation

  2026-06-05

  Song et al. (2025) reveal that targeted activation of TRPV1+ peripheral somatosensory nerves at the nape rapidly suppresses systemic inflammation via a somato-autonomic reflex. This study uncovers a neural-immune circuit, providing mechanistic insight with implications for translational inflammation research and experimental protocol design.

• Oridonin Modulates Osteoclastogenesis via MAPK/NF-κB Pathway

  2026-06-04

  This study demonstrates that oridonin can both suppress thioacetamide-induced osteoclastogenesis and restore osteoblast differentiation by targeting the MAPK/NF-κB and BMP-2/RUNX2 pathways, respectively. The findings provide mechanistic insight into dual-action strategies for osteoporosis, highlighting new directions for anti-inflammatory and bone-protective research.

• β-Elemene in Obesity and Neuroprotection: Applied Protocols

  2026-06-04

  β-Elemene bridges adipogenesis inhibition and neuroprotection, offering researchers a rare tool for dissecting metabolic and neural pathways. This guide translates the latest reference study and benchmarking resources into robust workflows, actionable protocol parameters, and troubleshooting strategies for advanced cell biology applications.

• 2'3'-cGAMP (sodium salt): Applied Workflows in cGAS-STING Re

  2026-06-03

  2'3'-cGAMP (sodium salt) enables precision activation of the cGAS-STING pathway, supporting robust studies of innate immune signaling and immunotherapy. Its reproducible performance, water solubility, and benchmark potency make it indispensable for dissecting type I interferon responses and overcoming experimental bottlenecks.

16088 records 1/1073 page Next 12345 下5页 Last page